Role of RNA-mediated danger signals in regulating TAAD development
RNA介导的危险信号在调节TAAD发展中的作用
基本信息
- 批准号:10456622
- 负责人:
- 金额:$ 44.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:Abdominal Aortic AneurysmAddressAngiotensin IIAnti-Inflammatory AgentsAortaAortic AneurysmAttenuatedAutocrine CommunicationAutomobile DrivingB-Cell ActivationBindingBone MarrowCXCL10 geneCardiovascular DiseasesCell LineCell modelCellsChestChronicClinicalDendritic CellsDevelopmentDiseaseDissectionEnvironmentEventFemaleFire - disastersGenderGenesGeneticGenetic Predisposition to DiseaseGrowthHistologicHomeostasisHospital MortalityHumanHydroxychloroquineImmuneImmune responseImmunologic ReceptorsInfiltrationInflammationInflammatory ResponseInjuryInterferon-alphaInterleukin-1 betaLeadLigandsLinkLocationMMP2 geneMMP9 geneMediatingMicroRNAsModelingMolecularMusNatural ImmunityNecrosisOperative Surgical ProceduresOutcomeParacrine CommunicationPathogenesisPathogenicityPathway interactionsPatternPharmacologic SubstancePharmacologyPlayPositioning AttributePreventionProductionRIPK3 geneRNAReagentReceptor SignalingRegulationReportingRoleSeveritiesSignal PathwaySignal TransductionSmooth Muscle MyocytesSterilityStressSystemT-LymphocyteTLR3 geneTLR7 geneTNF geneTestingThoracic Aortic AneurysmTissuesToll-like receptorsTransforming Growth Factor betaTransforming Growth FactorsUp-RegulationY Chromosomeascending aortacell typecytokineexperimental studygenetic risk factorimmune activationimprovedinhibitormalemembermouse modelneutrophilnoveloxidationpathogenpostnatalpreventreceptorrepairedresearch clinical testingsensortherapeutically effectivetissue repair
项目摘要
ABSTRACT
Thoracic aortic aneurysms and dissections (TAAD), particularly type A dissections, are a devastating disease,
with an in-hospital mortality rate up to 25%. Although ascending aortic aneurysms and dissections (AADs) may
result from genetic predispositions, more than 70% of cases are sporadic. Currently, surgical repair is the only
available treatment. Development of pharmacological prevention agents remains a challenging task due to poor
understanding of the cellular and molecular mechanisms responsible for pathogenesis of AADs. We have
reported that postnatal deletion of smooth muscle cell (SMC) transforming growth factor-β type I receptors
(Tgfbr1iko) induces AAD formation in male mice. Recently, we developed a novel X-linked Cre line that drives
Tgfbr1iko and AAD formation in female mice with similar efficiency and severity compared to its parental Y-linked
myh11-CreERTM strain. One of the histological hallmarks of AADs is chronic inflammation, characterized by
progressive SMC depletion, immune cell infiltration, and matrix degradation. These events create a perfect
environment for activation of the innate immunity. Specifically, molecules produced by dying SMCs can function
as damage-associated molecular patterns to activate pathogen recognition receptors (PRRs) via autocrine
and/or paracrine signaling, a scenario currently under rigorous experimental and clinical evaluation for other
chronic conditions. Therefore, we explored activation of the innate immunity in our AAD models and obtained
results as follows. 1) AAD formation was associated with RNA oxidation, upregulation of toll-like receptor (TLR)-
7, and SMC necroptosis. 2) AAD-, but not normal aorta-derived RNAs triggered inflammatory response in
immune cells. 3) More importantly, treatment of mice with reagents inhibiting endosomal TLRs attenuated AAD
formation. These novel findings led to our overall hypothesis that self-RNAs trigger TLR7-mediated danger
signals to promote TAAD development. This hypothesis will be tested through two interrelated Specific Aims.
Specific Aim 1 will determine the contribution of self-RNAs to activation of innate immune injury and AAD
formation. Studies under this Aim will address three key issues. 1) What makes self-RNAs pathogenic? 2) How
self-RNAs regulate the RIPK3/pMLKL pathway to induce necroptosis of SMCs? 3) What is the role of necroptosis
of SMCs in AAD formation? Specific Aim 2 will identify PRR(s) that sense self-RNAs to promote AAD formation.
Experiments proposed under Specific Aim 2 will answer two key questions. 1) Are self-RNAs sensed by the
same endosomal TLR member(s) in different type of cells across species (i.e. mouse vs. human)? 2) Is genetic
or pharmacological inhibition of the responsible RNA-sensing TLR(s) sufficient to alter the course of AAD
formation? Our novel AAD mouse models have placed us in a unique position to address these issues with
mouse AADs of either gender. Completion of this project will provide a better understanding of the mechanisms
that nourish chronic inflammation during AAD formation and may lead to a new direction for the development of
pharmacological preventions against initiation and progression of AADs.
抽象的
胸主动脉瘤和夹层 (TAAD),特别是 A 型夹层,是一种毁灭性的疾病,
尽管升主动脉瘤和夹层 (AAD) 可能导致院内死亡率高达 25%。
由于遗传因素,70%以上的病例是散发性的,目前,手术修复是唯一的方法。
由于治疗效果不佳,药物预防剂的开发仍然是一项具有挑战性的任务。
我们已经了解了 AAD 发病机制的细胞和分子机制。
报道称,出生后平滑肌细胞(SMC)转化生长因子-β I 型受体缺失
(Tgfbr1iko) 诱导雄性小鼠形成 AAD 最近,我们开发了一种新型 X 连锁 Cre 系,可驱动 AAD 形成。
与亲代 Y 连锁小鼠相比,雌性小鼠中 Tgfbr1iko 和 AAD 的形成具有相似的效率和严重程度
myh11-CreERTM 菌株 AAD 的组织学特征之一是慢性炎症,其特征是
渐进的 SMC 耗竭、免疫细胞浸润和基质降解这些事件创造了完美的结果。
具体来说,死亡的 SMC 产生的分子可以发挥作用。
作为损伤相关分子模式,通过自分泌激活病原体识别受体(PRR)
和/或旁分泌信号传导,目前正在对其他情况进行严格的实验和临床评估
因此,我们探索了 AAD 模型中先天免疫的激活并获得了结果。
结果如下: 1) AAD 的形成与 RNA 氧化、Toll 样受体 (TLR) 的上调有关。
7、SMC 坏死性凋亡 2) AAD 而非正常主动脉来源的 RNA 引发炎症反应。
3) 更重要的是,用抑制内体 TLR 的试剂治疗小鼠可减弱 AAD。
这些新的发现得出了我们的总体假设:自身 RNA 会引发 TLR7 介导的危险。
促进 TAAD 发展的信号将通过两个相互关联的具体目标进行检验。
具体目标 1 将确定自身 RNA 对先天免疫损伤和 AAD 激活的贡献
该目标下的研究将解决三个关键问题:1)什么使自身 RNA 致病?
自身RNA调节RIPK3/pMLKL通路诱导SMCs坏死性凋亡? 3) 坏死性凋亡的作用是什么?
SMC 在 AAD 形成中的作用?特定目标 2 将识别感知自身 RNA 的 PRR 以促进 AAD 形成。
具体目标 2 下提出的实验将回答两个关键问题:1) 自身 RNA 是否被感知。
不同物种的不同类型细胞中存在相同的内体 TLR 成员(即小鼠与人类) 2) 是遗传的吗?
或对负责的 RNA 感应 TLR 进行药物抑制,足以改变 AAD 的进程
我们的新型 AAD 小鼠模型使我们处于解决这些问题的独特地位
完成该项目将有助于更好地理解该机制。
在 AAD 形成过程中滋养慢性炎症,并可能为 AAD 的发展带来新的方向
针对 AAD 发生和进展的药物预防。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zhihua Jiang其他文献
Zhihua Jiang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zhihua Jiang', 18)}}的其他基金
Immune injury as a driver for the development of ascending aortic aneurysms and dissections
免疫损伤是升主动脉瘤和夹层发展的驱动因素
- 批准号:
10204109 - 财政年份:2020
- 资助金额:
$ 44.95万 - 项目类别:
Immune injury as a driver for the development of ascending aortic aneurysms and dissections
免疫损伤是升主动脉瘤和夹层发展的驱动因素
- 批准号:
10454854 - 财政年份:2020
- 资助金额:
$ 44.95万 - 项目类别:
Immune injury as a driver for the development of ascending aortic aneurysms and dissections
免疫损伤是升主动脉瘤和夹层发展的驱动因素
- 批准号:
10029084 - 财政年份:2020
- 资助金额:
$ 44.95万 - 项目类别:
Immune injury as a driver for the development of ascending aortic aneurysms and dissections
免疫损伤是升主动脉瘤和夹层发展的驱动因素
- 批准号:
10646241 - 财政年份:2020
- 资助金额:
$ 44.95万 - 项目类别:
Role of RNA-mediated danger signals in regulating TAAD development
RNA介导的危险信号在调节TAAD发展中的作用
- 批准号:
10218266 - 财政年份:2019
- 资助金额:
$ 44.95万 - 项目类别:
The Dichotomy of Alk1 and Alk5 Signaling Pathways in Vascular Response to Injury
Alk1 和 Alk5 信号通路在血管损伤反应中的二分法
- 批准号:
8465262 - 财政年份:2011
- 资助金额:
$ 44.95万 - 项目类别:
The Dichotomy of Alk1 and Alk5 Signaling Pathways in Vascular Response to Injury
Alk1 和 Alk5 信号通路在血管损伤反应中的二分法
- 批准号:
8300081 - 财政年份:2011
- 资助金额:
$ 44.95万 - 项目类别:
The Dichotomy of Alk1 and Alk5 Signaling Pathways in Vascular Response to Injury
Alk1 和 Alk5 信号通路在血管损伤反应中的二分法
- 批准号:
8116243 - 财政年份:2011
- 资助金额:
$ 44.95万 - 项目类别:
The Dichotomy of Alk1 and Alk5 Signaling Pathways in Vascular Response to Injury
Alk1 和 Alk5 信号通路在血管损伤反应中的二分法
- 批准号:
8668130 - 财政年份:2011
- 资助金额:
$ 44.95万 - 项目类别:
The Dichotomy of Alk1 and Alk5 Signaling Pathways in Vascular Response to Injury
Alk1 和 Alk5 信号通路在血管损伤反应中的二分法
- 批准号:
8847768 - 财政年份:2011
- 资助金额:
$ 44.95万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Vascular Smooth Muscle Protein Quality Control and Aortic Aneurysm Formation
血管平滑肌蛋白质量控制与主动脉瘤形成
- 批准号:
10714562 - 财政年份:2023
- 资助金额:
$ 44.95万 - 项目类别:
Vascular smooth muscle cell ferroptosis and abdominal aortic aneurysm
血管平滑肌细胞铁死亡与腹主动脉瘤
- 批准号:
10733477 - 财政年份:2023
- 资助金额:
$ 44.95万 - 项目类别:
Macrophage Pyroptosis in Abdominal Aortic Aneurysm
腹主动脉瘤巨噬细胞焦亡
- 批准号:
10532383 - 财政年份:2021
- 资助金额:
$ 44.95万 - 项目类别: